Modes of podocyte death in diabetic kidney disease: an update
- PMID: 35201595
- DOI: 10.1007/s40620-022-01269-1
Modes of podocyte death in diabetic kidney disease: an update
Abstract
Diabetic kidney disease (DKD) accounts for a large proportion of end-stage renal diseases that require renal replacement therapies including dialysis and transplantation. Therefore, it is critical to understand the occurrence and development of DKD. Podocytes are mainly injured during the development of DKD, ultimately leading to their extensive death and loss. In turn, the injury and death of glomerular podocytes are also the main culprits of DKD. This review introduces the characteristics of podocytes and summarizes the modes of their death in DKD, including apoptosis, autophagy, mitotic catastrophe (MC), anoikis, necroptosis, and pyroptosis. Apoptosis is characterized by nuclear condensation and the formation of apoptotic bodies, and it exerts a different effect from autophagy in mediating DKD-induced podocyte loss. MC mediates a faulty mitotic process while anoikis separates podocytes from the basement membrane. Moreover, pyroptosis activates inflammatory factors to aggravate podocyte injuries whilst necroptosis drives signaling cascades, such as receptor-interacting protein kinases 1 and 3 and mixed lineage kinase domain-like, ultimately promoting the death of podocytes. In conclusion, a thorough knowledge of the modes of podocyte death in DKD can help us understand the development of DKD and lay the foundation for strategies in DKD disease therapy.
Keywords: Apoptosis; Autophagy; Diabetic kidney disease; Mitotic catastrophe; Podocyte death.
© 2022. The Author(s) under exclusive licence to Italian Society of Nephrology.
Similar articles
-
Research progress on multiple cell death pathways of podocytes in diabetic kidney disease.Mol Med. 2023 Oct 12;29(1):135. doi: 10.1186/s10020-023-00732-4. Mol Med. 2023. PMID: 37828444 Free PMC article. Review.
-
Podocyte programmed cell death in diabetic kidney disease: Molecular mechanisms and therapeutic prospects.Biomed Pharmacother. 2024 Aug;177:117140. doi: 10.1016/j.biopha.2024.117140. Epub 2024 Jul 16. Biomed Pharmacother. 2024. PMID: 39018872 Review.
-
TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease.Kidney Int. 2025 Feb;107(2):317-331. doi: 10.1016/j.kint.2024.10.026. Epub 2024 Nov 19. Kidney Int. 2025. PMID: 39571905
-
[Effects and mechanisms of total flavones of Abelmoschus manihot in inhibiting podocyte necroptosis and renal fibrosis in diabetic kidney disease].Zhongguo Zhong Yao Za Zhi. 2023 Aug;48(15):4137-4146. doi: 10.19540/j.cnki.cjcmm.20230417.701. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37802782 Chinese.
-
JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.Eur J Pharmacol. 2021 Jul 5;902:174121. doi: 10.1016/j.ejphar.2021.174121. Epub 2021 Apr 24. Eur J Pharmacol. 2021. PMID: 33901462
Cited by
-
Role of Hippo/ACSL4 axis in ferroptosis-induced pericyte loss and vascular dysfunction in sepsis.Redox Biol. 2024 Dec;78:103353. doi: 10.1016/j.redox.2024.103353. Epub 2024 Nov 12. Redox Biol. 2024. PMID: 39566164 Free PMC article.
-
Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease.Diabetologia. 2025 May;68(5):1057-1075. doi: 10.1007/s00125-025-06385-8. Epub 2025 Feb 27. Diabetologia. 2025. PMID: 40014139
-
Non-linear association of triglyceride-glucose index with cardiovascular and all-cause mortality in T2DM patients with diabetic kidney disease: NHANES 2001-2018 retrospective cohort study.Lipids Health Dis. 2024 Aug 17;23(1):253. doi: 10.1186/s12944-024-02249-z. Lipids Health Dis. 2024. PMID: 39154178 Free PMC article.
-
Activation of acetyl-CoA synthetase 2 mediates kidney injury in diabetic nephropathy.JCI Insight. 2023 Oct 23;8(20):e165817. doi: 10.1172/jci.insight.165817. JCI Insight. 2023. PMID: 37870960 Free PMC article.
-
Machine learning based identification of anoikis related gene classification patterns and immunoinfiltration characteristics in diabetic nephropathy.Sci Rep. 2025 May 1;15(1):15271. doi: 10.1038/s41598-025-99395-w. Sci Rep. 2025. PMID: 40312440 Free PMC article.
References
-
- Brosius FC, Tuttle KR, Kretzler M (2016) JAK inhibition in the treatment of diabetic kidney disease. Diabetologia 59(8):1624–1627. https://doi.org/10.1007/s00125-016-4021-5 - DOI - PubMed - PMC
-
- Zhou D, Zhou M, Wang Z et al (2019) PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy. Cell Death Dis 10(7):524. https://doi.org/10.1038/s41419-019-1754-3 - DOI - PubMed - PMC
-
- Denhez B, Lizotte F, Guimond MO et al (2015) Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes. J Biol Chem 290(1):350–358. https://doi.org/10.1074/jbc.M114.612721 - DOI - PubMed
-
- Manda G, Checherita AI, Comanescu MV, Hinescu ME (2015) Redox signaling in diabetic nephropathy: hypertrophy versus death choices in mesangial cells and podocytes. Mediators Inflamm 2015:604208. https://doi.org/10.1155/2015/604208 - DOI - PubMed - PMC
-
- Li JJ, Kwak SJ, Jung DS et al (2007) Podocyte biology in diabetic nephropathy. Kidney Int Suppl 106:S36-42. https://doi.org/10.1038/sj.ki.5002384 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical